PARIS – L’Oréal is delving deeper into aesthetics with the acquisition of another 10 percent stake in Galderma Group AG, the pure-play dermatology leader worldwide and among the largest in injectable aesthetics, which it originally cofounded.

The purchase was made from a consortium led by EQT, including Sunshine SwissCo GmbH (SSCO), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte Ltd. – which all act in coordination as sellers – for an undisclosed amount.

L’Oréal now holds 20 percent of Galderma’s share capital.

“Aesthetics is a key adjacency to our core beauty business that we are keen to continue to explore,” Nicolas Hieronimus, L’Oréal chief executive officer, said in a statement on Monday. “Our initial strategic investment made in 2024 in Galderma has proven v

See Full Page